For example, small molecule inhibitors of Axl have activity in lapatinib-resistant breast cancer models [22], and our data show that both AZD8931- and lapatinib-resistant cells are more sensitive than the parental cells to foretinib, which inhibits Axl tyrosine kinase activity. The gene discussed is AXL; the disease is breast carcinoma.